No connection

Search Results

ANDE

NEUTRAL
$70.74 Live
The Andersons, Inc. · NASDAQ
Target $73.33 (+3.7%)
$31.03 52W Range $71.54

At a glance

Key valuation, profitability, growth, and risk metrics.

Unlock key metrics

Market cap, P/E, ROE, margins, leverage and more.

AI Analysis

AI-powered fundamental assessment

Confidence
72%
The Andersons, Inc. (ANDE) exhibits mixed signals across the Advanced Deterministic Scorecard: a Piotroski F-Score of 4/9 indicates weak financial health, while the absence of an Altman Z-Score raises concern about default risk. The stock trades near its intrinsic value of $82.31 but at a premium to the Graham Number of $48.28, suggesting high growth expectations are priced in. Despite strong earnings growth (51.4% YoY) and a recent surge in EPS (142.9% Q/Q), revenue has declined sharply (-18.8% YoY), signaling underlying business headwinds. Insider selling activity and a bearish technical trend further temper optimism.

Key Strengths

Strong earnings growth (51.4% YoY) and recent Q/Q EPS surge (+142.9%) indicate operational recovery or one-time gains
Forward P/E of 12.59 suggests market expects improved profitability despite current high trailing P/E
Analyst consensus is strong_buy with a target price of $73.33, implying upside potential
Graham Number ($48.28) and intrinsic value ($82.31) provide a clear value framework, with the latter suggesting upside if growth is sustainable
Historical earnings surprise average of 20.14% over last 4 quarters reflects consistent beat potential

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health, signaling potential issues in profitability, leverage, or cash flow
Revenue declined 18.8% YoY, which is concerning for a consumer defensive stock and contradicts earnings growth
Insider selling activity (2 transactions, $0.18M) with no buys suggests internal skepticism
Technical trend is bearish (10/100), and price is near 52-week high ($71.54), limiting near-term upside
Lack of Altman Z-Score and missing financials (cash, debt, FCF) prevent full health assessment; high debt/equity (0.75) and low quick ratio (0.45) are red flags
AI Fair Value Estimate
Based on comprehensive analysis
$82.31
+16.4% above current price

Performance Snowflake

Multi-dimensional AI analysis across 5 key categories

Unlock AI-Powered Analysis

See Value, Future Performance, Past Performance, Financial Health & Dividend scores

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Unlock Price Charts

View historical price trends and analyst targets

Historical Performance Trends

Long-term financial metrics and growth patterns

Unlock Historical Data

View 3-year revenue, profit margins, and growth trends

Valuation Metrics

Key valuation ratios and pricing indicators

Sign up to view

P/E, P/B, P/S, EV/EBITDA and more

Profitability, Growth & Financial Health

Detailed profit margins, ROE, debt ratios, and liquidity metrics

Unlock Detailed Metrics

View ROE, Operating Margin, Debt/Equity, Current Ratio and more

Sector Comparison & Peer Analysis

Compare ANDE against industry averages and similar companies

Unlock Sector Insights

See how ANDE compares to competitors and industry standards

Insider Trading & Analyst Ratings

Track insider transactions and Wall Street analyst recommendations

Unlock Insider Data

See recent insider buys/sells and analyst price targets

Past News Coverage

Recent headlines mentioning ANDE from our newsroom.

Newest → oldest

See the full ANDE analysis

Free signup • Unlock all metrics • No credit card required

TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile